A new systematic review and meta-analysis of randomized controlled trials has found that zinc supplementation can improve insulin resistance and reduce inflammation and oxidative stress in people with diabetes and related conditions. Notably, however, zinc did not significantly improve every measure of blood sugar control. Rather than this diminishing the importance of nutrition, the findings instead highlight a fundamental problem with the way nutritional therapies are often investigated: complex chronic diseases such as diabetes are unlikely to be optimally controlled by any single nutrient acting alone.

Zinc plays an important role in the body’s handling of insulin. Among other things, it is involved in the synthesis, storage and release of insulin from the beta cells of the pancreas. Zinc deficiency has also been associated with impaired insulin signaling, increased oxidative stress and inflammation – processes closely involved in the development and progression of type 2 diabetes.

Published in the Endocrinology, Diabetes & Metabolism journal, the new study analyzed 18 randomized controlled trials involving a total of 1,023 people with diabetes, gestational diabetes, or prediabetes. The researchers found that those receiving zinc supplements experienced significant improvements in insulin resistance. Levels of insulin circulating in the blood also fell, potentially indicating that the body was able to use insulin more efficiently.

Significant improvements were additionally seen in markers of inflammation and oxidative stress. C-reactive protein, a widely used measure of inflammation, decreased, as did malondialdehyde, a marker of oxidative damage. Total antioxidant capacity increased. These findings are potentially important because diabetes is not simply a disease of elevated blood sugar. The metabolic disturbances associated with it can damage blood vessels, nerves, kidneys, eyes, and other tissues throughout the body.

Why didn’t zinc improve everything?

Significantly, however, the results were not uniformly positive. Zinc supplementation did not produce a statistically significant improvement in either fasting glucose or HbA1c, a measure reflecting average blood glucose levels over the preceding few months. Lipid findings were also mixed, with total cholesterol decreasing slightly but LDL cholesterol showing a small increase.

The researchers were therefore appropriately cautious. While concluding that zinc supplementation was associated with improvements in insulin resistance, inflammation and oxidative stress, they said larger and longer-lasting clinical trials are needed before broad recommendations can be made.

There were also important differences between the 18 trials, including in the types of diabetes studied, participants’ nutritional status, zinc doses, and length of supplementation. Several outcomes showed substantial statistical variation between studies. Some of the studies also provided zinc alongside other micronutrients or natural compounds, making it difficult to determine how much of the observed benefit was attributable to zinc alone. But there is also another way of looking at these mixed results.

Why should we expect one individual nutrient, acting alone, to correct all of the various metabolic disturbances involved in a complex disease such as diabetes? The human body does not use micronutrients in isolation. Vitamins, minerals, amino acids, and other natural substances participate in interconnected biochemical pathways, frequently depending upon one another to perform their cellular functions.

This is precisely why Dr. Matthias Rath’s Cellular Medicine approach to chronic disease has long focused on specific combinations of micronutrients rather than individual nutrients used in isolation.

Targeting diabetes from several directions simultaneously

Research conducted at the Dr. Rath Research Institute has investigated this multi-nutrient approach to diabetes at the cellular level. In a 2022 study, scientists tested specific combinations of vitamins, minerals, and other natural compounds on several cellular processes involved in diabetic metabolism. They found that the combinations could simultaneously affect glucose uptake by skeletal muscle cells, insulin secretion by pancreatic cells, and cellular protection against damage caused by advanced glycation end products – harmful compounds produced when sugars react with proteins and other molecules in the body.

Glucose uptake by skeletal muscle cells increased by as much as 450 percent. When insulin was present, the researchers reported an increase of up to 1,445 percent over controls. The nutrient combination also increased insulin secretion from pancreatic cells by more than 230 percent.

These were cell-culture experiments, rather than a clinical trial in diabetes patients. Nevertheless, the results illustrate an important principle: appropriately selected micronutrients can act simultaneously upon several different cellular mechanisms involved in glucose metabolism.

Earlier research from the Dr. Rath Research Institute reached similarly interesting findings in an animal model. Published in the Molecular Medicine Reports journal in 2011, the study examined young mice receiving a high-fructose diet designed to induce features of metabolic syndrome, a condition closely associated with the subsequent development of type 2 diabetes. One group received a defined mixture of nutrients, while another received the diabetes drug metformin. The mice receiving the nutrient mixture showed significant reductions in systolic blood pressure, total cholesterol, and fructosamine – a marker reflecting blood sugar control – compared with animals receiving fructose alone. Serum glucose did not differ significantly between the groups.

Taken together, these studies illustrate why a multi-nutrient approach deserves serious consideration in diabetes.

Diabetes is more than just a blood sugar problem

Conventional diabetes treatment largely revolves around controlling elevated blood glucose. While controlling blood sugar is clearly important, diabetes involves considerably more than this single measurement. Insulin resistance, chronic inflammation, oxidative stress, impaired cellular energy metabolism, and damage to blood vessels and other tissues all contribute to the disease and its complications.

The new zinc meta-analysis itself illustrates this complexity particularly well. Zinc produced significant benefits in some of these areas while fasting glucose and HbA1c did not significantly change.

Seen from this perspective, the findings should not be interpreted as showing that zinc “doesn’t work” for diabetes. They show something much more interesting: a single micronutrient can influence important mechanisms involved in the disease without being sufficient on its own to normalize the entire metabolic picture.

Moving beyond the single-nutrient mindset

For decades, nutritional research has frequently attempted to assess vitamins and other micronutrients according to a pharmaceutical-style model: isolate one substance, administer it on its own, and determine whether it changes a particular disease marker. 

Such studies can tell us whether an individual nutrient has a biological effect. The new zinc analysis clearly suggests that zinc does. But this approach may underestimate what nutrition can achieve when nutrients are provided in scientifically selected combinations.

Nobody would expect an orchestra to reproduce a symphony using a single instrument. Biological systems are similarly interconnected. Enzymes, signaling pathways, antioxidant defenses, and cellular-energy systems require multiple micronutrients working together.

The new zinc study therefore represents another useful piece of the diabetes puzzle. It provides evidence from randomized clinical trials that improving micronutrient supply can beneficially influence insulin resistance, inflammation, and oxidative stress.

The next logical step is to move beyond repeatedly asking what individual nutrients can achieve on their own and devote far greater research attention to carefully designed combinations of micronutrients capable of targeting the multiple cellular processes underlying diabetes simultaneously. For the 830 million people worldwide now living with diabetes, it is an approach whose potential should not be underestimated.

Disclaimer: This content is for educational purposes only and is not intended as medical advice, diagnosis, or treatment. Consult a qualified healthcare professional before making changes to your health or treatment.